Phase II Trial of Intermittent Therapy in Patients with Metastatic Renal Cell Carcinoma Treated with Front-line Ipilimumab and Nivolumab.

Moshe C OrnsteinLaeth GeorgeWei WeiC Marcela Diaz-MonteroPat RaymanAllison MartinArnab BasuKathryn E BeckermannAmanda NizamChristopher E WeeTimothy D GilliganShilpa GuptaBrian I Rini

Published in: Clinical genitourinary cancer (2024)

NCT03126331 [Date of registration 4/27/2017; https://clinicaltrials.gov/ct2/show/NCT03126331].

Keyphrases

metastatic renal cell carcinoma
image quality
computed tomography
dual energy
contrast enhanced
high intensity
open label
positron emission tomography
newly diagnosed
clinical trial
randomized controlled trial
placebo controlled
study protocol